DiaMedica Therapeutics Inc.

DMAC | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.37

+$0.11 (+1.52%)

Sep 22, 2026, 12:30 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	15.65M	3.03M	4.54M	4.73M	4.71M	7.41M
Short-Term Investments	44.24M	41.12M	48.35M	28.77M	40.41M	20.1M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	400K	1.31M	n/a	n/a	n/a	n/a
Receivables	258K	236K	369K	82K	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	481K	227K	n/a	n/a	243K	350K
Total Current Assets	60.63M	44.61M	53.68M	33.84M	45.44M	27.92M
Property-Plant & Equipment	342K	427K	485K	560K	112K	174K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	742K	1.74M	485K	560K	112K	174K
Total Assets	61.37M	46.35M	54.16M	34.4M	45.55M	28.1M
Account Payables	1.48M	940K	926K	734K	509K	1.1M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.38M	1.06M	766K	667K	484K	n/a
Total Current Liabilities	5.13M	5.39M	2.79M	2.17M	1.52M	2.03M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	128K	237K	317K	400K	3K	53K
Total Liabilities	5.26M	5.63M	3.1M	2.57M	1.53M	2.08M
Total Debt	240K	340K	400K	469K	52K	118K
Book Value	56.11M	40.72M	51.06M	31.83M	44.02M	26.01M
Book Value Per Share	1.19	1.01	1.57	1.20	2.12	1.66
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-172.77M	-140M	-115.56M	-96.18M	-82.5M	-68.91M
Comprehensive Income	50K	23K	6K	-74K	-51K	-2K
Shareholders Equity	56.11M	40.72M	51.06M	31.83M	44.02M	26.01M
Total Investments	44.24M	41.12M	48.35M	28.77M	40.41M	20.1M